Used as a key intermediate in pharmaceutical synthesis, particularly in the preparation of kinase inhibitors. Its boronate ester group enables Suzuki-Miyaura cross-coupling reactions, allowing efficient formation of carbon-carbon bonds in drug development. Commonly applied in the synthesis of bioactive molecules targeting cancer and inflammatory diseases. Stable and selective, it supports high-yield transformations under mild conditions, making it valuable in medicinal chemistry and late-stage functionalization of complex molecules.